Advanced Filters
noise
Found 65,447 clinical trials
N Nida Amin, PhD Scholar (Optometry)

Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes

The aim of this clinical trial is to learn if omega-3 fatty acid supplements help maintain healthy blood vessels in the eyes of adults with type 1 diabetes. It will also learn about the safety of omega-3 supplements. The main questions it aims to answer are: Do omega-3 supplements improve …

10 - 45 years of age All Phase N/A
H Haitao Zhao, MD

An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy.

This is a multicenter, non-randomized, umbrella, open-label phase II clinical study, aiming to observe and evaluate, as well as explore the efficacy and safety of precision targeted therapy based on NGS technology for IDH1-mutated patients, specifically the combination of ivosidenib with multi-target tyrosine kinase inhibitors represented by lenvatinib or PD-1/PD-L1 …

18 - 80 years of age All Phase 2
C Chingching Foocharoen, MD

Topical Cannabidiol Lotion for Pruritus Relief in Scleroderma

Itching is one of the common symptoms found in patients with scleroderma, with a prevalence of about 42-62%, and it often occurs in the early stages of the disease. The mechanisms of itching are still unclear, and current treatments have not yet shown any clear efficacy in alleviating itching caused …

18 - 70 years of age All Phase 3

Absolute Bioavailability Study of Cizutamig in Healthy Adult Participants

The purpose of this study is to determine the absolute bioavailability of SC administered cizutamig in healthy adult participants.

18 - 65 years of age All Phase 1
N Nutrition and Dietetics

A Single Arm Intervention Study to Assess the Acceptability, Tolerance and Ease of Use of Wilbo's Blends+ (Commercial Enteral Feed Based on Real Food) When Used as Part of a Dietitian Prescribed Enteral Feeding Plan

The goal of this observational study is to learn if tube-fed children and young people (age 3-15 years) find Wilbo's Blends+ (a new nutritionally complete enteral formula containing real food ingredients) acceptable, tolerable and easy to use. The main question it aims to answer is: Is Wilbo's Blends+ acceptable when …

3 - 15 years of age All Phase N/A
M Mathieu GUEUGNON

Impact of Motor Imagery in the Functional Rehabilitation of Patients With Chronic Low Back Pain: a Randomised Controlled Trial

Non-specific low back pain (NSLBP) is a very common condition and one of the leading causes of disability worldwide. It has a significant impact on quality of life, with functional, locomotor and psychological repercussions, and is often associated with kinesiophobia (excessive fear of movement due to apprehension related to pain …

18 years of age All Phase N/A
S Sergio Felipe Pinzón Mariño, Dr.

Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women

This study aims to compare two oral iron treatments, Sucrosomial® Iron and Ferric Maltol, in women with mild to moderate iron deficiency anemia. Many patients experience gastrointestinal side effects or poor tolerability with traditional iron supplements, which may limit adherence. Participants will be randomly assigned to receive either Sucrosomial® Iron …

18 years of age Female Phase 4
R Ramazan Yilmaz, asist. prof

Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger

Patients aged 18-75 years who present with trigger finger to a tertiary rehabilitation hospital and agree to participate will be included in the study. Participants will be randomly allocated into three groups using block randomization. The first group will use a static finger splint that blocks the proximal interphalangeal joint …

18 - 75 years of age All Phase N/A
G Giuseppe Derosa, MD, PhD

Effect of a Food Supplement on Blood Glucose Levels in Patients With Impaired Glucose Values

The primary objective is to evaluate the efficacy of Euglycem® plus recommended standard diet on reducing FPG compared to baseline and to recommended standard diet alone after 3 months

18 years of age All Phase N/A

Study of ZG005 in Patients With Advanced Solid Tumors

This is an open-label, multicenter, Phase II clinical trial, designed to evaluate the efficacy and safety of ZG005 in patients with advanced solid tumors who have previously failed or are intolerant to standard treatment.

18 - 75 years of age All Phase 2

Simplify language using AI